HIGHLIGHTS
- who: Rheumatoid Arthritis, on Methotrexate and Satoshi, Shinohara from the Tochigi Rheumatology Clinic, Ekimaedori, Utsunomiya, Tochigi, Japan have published the research: Case Report Time Course of Antispike Antibody Titer after Administration of BNT162b2 mRNA COVID-19 Vaccine in a Patient with Rheumatoid Arthritis on Methotrexate, in the Journal: Case Reports in Rheumatology of 19/04/2023
- how: Details of the characteristics of the participants in this study are presented in Table 1. Lukaszuk et_al monitored anti-S antibody titers in a female patient with RA taking MTX and in 119 HCWs for 180 days after . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.